High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam

References

1. Brisse S., Verhoef J. 2001; Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping. Int J Syst Evol Microbiol 51:915–924 [CrossRef]
   [Google Scholar]
2. Cattoir V., Poirel L., Mazel D., Soussy C. J., Nordmann P. 2007a; Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob Agents Chemother 51:2650–2651 [CrossRef]
   [Google Scholar]
3. Cattoir V., Weill F. X., Poirel L., Fabre L., Soussy C. J., Nordmann P. 2007b; Prevalence of qnr genes in Salmonella in France. J Antimicrob Chemother 59:751–754 [CrossRef]
   [Google Scholar]
4. Cattoir V., Poirel L., Aubert C., Soussy C. J., Nordmann P. 2008a; Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerg Infect Dis 14:231–237 [CrossRef]
   [Google Scholar]
5. Cattoir V., Poirel L., Nordmann P. 2008b; Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob Agents Chemother 52:3801–3804 [CrossRef]
   [Google Scholar]
6. Chau T. T., Campbell J. I., Galindo C. M., Van Minh Hoang N., Diep T. S., Nga T. T., Van Vinh Chau N., Tuan P. Q., Page A. L. other authors 2007; Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 51:4315–4323 [CrossRef]
   [Google Scholar]
7. Chen Y. T., Shu H. Y., Li L. H., Liao T. L., Wu K. M., Shiau Y. R., Yan J. J., Su I. J., Tsai S. F., Lauderdale T. L. 2006; Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum- β -lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 50:3861–3866 [CrossRef]
   [Google Scholar]
8. CLSI 2007 Performance Standards For Antimicrobial Susceptibility Testing , 17th Informational Supplement, M100-S17 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
9. Gay K., Robicsek A., Strahilevitz J., Park C. H., Jacoby G., Barrett T. J., Medalla F., Chiller T. M., Hooper D. C. 2006; Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica . Clin Infect Dis 43:297–304 [CrossRef]
   [Google Scholar]
10. Hata M., Suzuki M., Matsumoto M., Takahashi M., Sato K., Ibe S., Sakae K. 2005; Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 49:801–803 [CrossRef]
    [Google Scholar]
11. Higgins P. G., Fluit A. C., Schmitz F. J. 2003; Fluoroquinolones: structure and target sites. Curr Drug Targets 4:181–190 [CrossRef]
    [Google Scholar]
12. Hu F. P., Xu X. G., Zhu D. M., Wang M. G. 2008; Coexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae . Acta Pharmacol Sin 29:320–324 [CrossRef]
    [Google Scholar]
13. Iabadene H., Messai Y., Ammari H., Ramdani-Bouguessa N., Lounes S., Bakour R., Arlet G. 2008; Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother 62:133–136 [CrossRef]
    [Google Scholar]
14. Jacoby G. A. 2005; Mechanisms of resistance to quinolones. Clin Infect Dis 41:S120–S126 [CrossRef]
    [Google Scholar]
15. Jacoby G. A., Walsh K. E., Mills D. M., Walker V. J., Oh H., Robicsek A., Hooper D. C. 2006; qnrB , another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 50:1178–1182 [CrossRef]
    [Google Scholar]
16. Jiang Y., Zhou Z., Qian Y., Wei Z., Yu Y., Hu S., Li L. 2008; Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum β -lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother 61:1003–1006 [CrossRef]
    [Google Scholar]
17. Kado C. I., Liu S. T. 1981; Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145:1365–1373
    [Google Scholar]
18. Ma J., Zeng Z., Chen Z., Xu X., Wang X., Deng Y., Lü D., Huang L., Zhang Y. other authors 2009; High prevalence of plasmid-mediated quinolone resistance determinants qnr , aac(6')-Ib-cr and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob Agents Chemother 53:519–524 [CrossRef]
    [Google Scholar]
19. Melano R., Corso A., Petroni A., Centron D., Orman B., Pereyra A., Moreno N., Galas M. 2003; Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum β -lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina. J Antimicrob Chemother 52:36–42 [CrossRef]
    [Google Scholar]
20. Mendes R. E., Bell J. M., Turnidge J. D., Yang Q., Yu Y., Sun Z., Jones R. N. 2008; Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid ( bla _KPC-2 plus qnrB4 ) and a bla _IMP-4 gene. Antimicrob Agents Chemother 52:798–799 [CrossRef]
    [Google Scholar]
21. Oktem I. M., Gulay Z., Bicmen M., Gur D. 2008; qnrA prevalence in extended-spectrum β -lactamase-positive Enterobacteriaceae isolates from Turkey. Jpn J Infect Dis 61:13–17
    [Google Scholar]
22. Pallecchi L., Bartoloni A., Fiorelli C., Mantella A., Di Maggio T., Gamboa H., Gotuzzo E., Kronvall G., Paradisi F., Rossolini G. M. 2007a; Rapid dissemination and diversity of CTX-M extended-spectrum β -lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 51:2720–2725 [CrossRef]
    [Google Scholar]
23. Pallecchi L., Lucchetti C., Bartoloni A., Bartalesi F., Mantella A., Gamboa H., Carattoli A., Paradisi F., Rossolini G. M. 2007b; Population structure and resistance genes in antibiotic-resistant bacteria from a remote community with minimal antibiotic exposure. Antimicrob Agents Chemother 51:1179–1184 [CrossRef]
    [Google Scholar]
24. Park C. H., Robicsek A., Jacoby G. A., Sahm D., Hooper D. C. 2006; Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50:3953–3955 [CrossRef]
    [Google Scholar]
25. Perichon B., Courvalin P., Galimand M. 2007; Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli . Antimicrob Agents Chemother 51:2464–2469 [CrossRef]
    [Google Scholar]
26. Robicsek A., Jacoby G. A., Hooper D. C. 2006a; The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6:629–640 [CrossRef]
    [Google Scholar]
27. Robicsek A., Strahilevitz J., Sahm D. F., Jacoby G. A., Hooper D. C. 2006b; qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50:2872–2874 [CrossRef]
    [Google Scholar]
28. Sannes M. R., Belongia E. A., Kieke B., Smith K., Kieke A., Vandermause M., Bender J., Clabots C., Winokur P., Johnson J. R. 2008; Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin. J Infect Dis 197:430–434 [CrossRef]
    [Google Scholar]
29. Schultsz C., Moussa M., van Ketel R., Tytgat G. N., Dankert J. 1997; Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol 50:573–579 [CrossRef]
    [Google Scholar]
30. Stobberingh E. E., van den Bogaard A. E. 2000; Spread of antibiotic resistance from food animals to man. Acta Vet Scand Suppl 93:47–50 (Discussion 51–42)
    [Google Scholar]
31. Strahilevitz J., Engelstein D., Adler A., Temper V., Moses A. E., Block C., Robicsek A. 2007; Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob Agents Chemother 51:3001–3003 [CrossRef]
    [Google Scholar]
32. Szabo D., Kocsis B., Rokusz L., Szentandrassy J., Katona K., Kristof K., Nagy K. 2008; First detection of plasmid-mediated, quinolone resistance determinants qnrA , qnrB , qnrS and aac(6')-Ib-cr in extended-spectrum β -lactamase (ESBL)-producing Enterobacteriaceae in Budapest, Hungary. J Antimicrob Chemother 62:630–632 [CrossRef]
    [Google Scholar]
33. Teuber M. 2001; Veterinary use and antibiotic resistance. Curr Opin Microbiol 4:493–499 [CrossRef]
    [Google Scholar]
34. Tran J. H., Jacoby G. A., Hooper D. C. 2005a; Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob Agents Chemother 49:3050–3052 [CrossRef]
    [Google Scholar]
35. Tran J. H., Jacoby G. A., Hooper D. C. 2005b; Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 49:118–125 [CrossRef]
    [Google Scholar]
36. Versalovic J., Koeuth T., Lupski J. R. 1991; Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19:6823–6831 [CrossRef]
    [Google Scholar]
37. Vila J., Ruiz J., Goni P., De Anta M. T. 1996; Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli . Antimicrob Agents Chemother 40:491–493
    [Google Scholar]
38. Wang A., Yang Y., Lu Q., Wang Y., Chen Y., Deng L., Ding H., Deng Q., Wang L., Shen X. 2008; Occurrence of qnr -positive clinical isolates in Klebsiella pneumoniae producing ESBL or AmpC-type β -lactamase from five pediatric hospitals in China. FEMS Microbiol Lett 283:112–116 [CrossRef]
    [Google Scholar]
39. Yamane K., Wachino J., Suzuki S., Kimura K., Shibata N., Kato H., Shibayama K., Konda T., Arakawa Y. 2007; New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51:3354–3360 [CrossRef]
    [Google Scholar]
40. Yamane K., Wachino J., Suzuki S., Arakawa Y. 2008; Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 52:1564–1566 [CrossRef]
    [Google Scholar]